• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of annrheumdAnnals of the Rheumatic DiseasesView this articleSubmit a manuscriptReceive email alertsContact usBMJ
Ann Rheum Dis. Nov 2003; 62(11): 1083–1087.
PMCID: PMC1754357

Endothelial nitric oxide synthase gene polymorphisms in Behçet's disease and rheumatic diseases with vasculitis

Abstract

Objective: To assess potential associations between Korean Behçet's disease (BD) or other rheumatic diseases with vasculitis and two polymorphisms of the endothelial nitric oxide synthase (eNOS) gene, which include the Glu298Asp polymorphism in exon 7 and a variable number of tandem repeats (VNTR) polymorphism in intron 4.

Methods: 65 patients with BD, 27 with rheumatic diseases with vasculitis, and 80 controls were studied. Analyses of the Glu298Asp polymorphism in exon 7 and VNTR polymorphism in intron 4 of the eNOS gene were made by the polymerase chain reaction (PCR)-restriction fragment length polymorphism technique and PCR genotyping, respectively. Additionally, HLA-B51 typing was performed in the BD group and controls by a two step PCR sequence-specific primers method.

Results: Significant differences in Glu298Asp genotype frequencies were found between the BD or vasculitis groups and the controls (BD group v controls: pcorr=0.006; vasculitis group v controls: p<0.001). The Asp298 frequency was much higher in the BD and vasculitis groups than in the controls. Even after stratification of the BD group based on the results of HLA-B51 testing, a significant association of the Glu298Asp polymorphism was still found (p=0.002, Mantel-Haenszel weighted odds ratio 4.3, 95% confidence interval 1.7 to 10.9). Distribution of the genotype frequencies in two eNOS gene polymorphisms was similar in connective tissue diseases-associated vasculitis and primary vasculitic syndromes. In contrast, distribution of alleles and genotypes of VNTR polymorphism did not differ between BD or vasculitis groups and the controls.

Conclusion: The Glu298Asp polymorphism in exon 7 of the eNOS gene seems to be a susceptibility gene for Korean BD and other rheumatic diseases.

Full Text

The Full Text of this article is available as a PDF (248K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Schmidt HH, Nau H, Wittfoht W, Gerlach J, Prescher KE, Klein MM, Niroomand F, Böhme E. Arginine is a physiological precursor of endothelium-derived nitric oxide. Eur J Pharmacol. 1988 Sep 13;154(2):213–216. [PubMed]
  • Palmer RM, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 1988 Jun 16;333(6174):664–666. [PubMed]
  • Clancy RM, Amin AR, Abramson SB. The role of nitric oxide in inflammation and immunity. Arthritis Rheum. 1998 Jul;41(7):1141–1151. [PubMed]
  • Stichtenoth DO, Frölich JC. Nitric oxide and inflammatory joint diseases. Br J Rheumatol. 1998 Mar;37(3):246–257. [PubMed]
  • Schmidt HH, Walter U. NO at work. Cell. 1994 Sep 23;78(6):919–925. [PubMed]
  • Lefer AM. Nitric oxide: nature's naturally occurring leukocyte inhibitor. Circulation. 1997 Feb 4;95(3):553–554. [PubMed]
  • Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol. 1996 Nov;271(5 Pt 1):C1424–C1437. [PubMed]
  • Marsden PA, Heng HH, Scherer SW, Stewart RJ, Hall AV, Shi XM, Tsui LC, Schappert KT. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem. 1993 Aug 15;268(23):17478–17488. [PubMed]
  • Wang XL, Wang J. Endothelial nitric oxide synthase gene sequence variations and vascular disease. Mol Genet Metab. 2000 Aug;70(4):241–251. [PubMed]
  • Shimasaki Y, Yasue H, Yoshimura M, Nakayama M, Kugiyama K, Ogawa H, Harada E, Masuda T, Koyama W, Saito Y, et al. Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. J Am Coll Cardiol. 1998 Jun;31(7):1506–1510. [PubMed]
  • Uwabo J, Soma M, Nakayama T, Kanmatsuse K. Association of a variable number of tandem repeats in the endothelial constitutive nitric oxide synthase gene with essential hypertension in Japanese. Am J Hypertens. 1998 Jan;11(1 Pt 1):125–128. [PubMed]
  • Wang XL, Sim AS, Badenhop RF, McCredie RM, Wilcken DE. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat Med. 1996 Jan;2(1):41–45. [PubMed]
  • Akar N, Akar E, Cin S, Deda G, Avcu F, Yalçin A. Endothelial nitric oxide synthase intron 4, 27 bp repeat polymorphism in Turkish patients with deep vein thrombosis and cerebrovascular accidents. Thromb Res. 1999 Apr 1;94(1):63–64. [PubMed]
  • Yokoyama K, Tsukada T, Matsuoka H, Hara S, Yamada A, Kawaguchi Y. High accumulation of endothelial nitric oxide synthase (ecNOS): a gene polymorphism in patients with end-stage renal disease. Nephron. 1998;79(3):360–361. [PubMed]
  • Sakane T, Takeno M, Suzuki N, Inaba G. Behçet's disease. N Engl J Med. 1999 Oct 21;341(17):1284–1291. [PubMed]
  • Koç Y, Güllü I, Akpek G, Akpolat T, Kansu E, Kiraz S, Batman F, Kansu T, Balkanci F, Akkaya S, et al. Vascular involvement in Behçet's disease. J Rheumatol. 1992 Mar;19(3):402–410. [PubMed]
  • Schmitz-Huebner U, Knop J. Evidence for an endothelial cell dysfunction in association with Behçet's disease. Thromb Res. 1984 May 15;34(4):277–285. [PubMed]
  • Chambers JC, Haskard DO, Kooner JS. Vascular endothelial function and oxidative stress mechanisms in patients with Behçet's syndrome. J Am Coll Cardiol. 2001 Feb;37(2):517–520. [PubMed]
  • Haznedaroglu IC, Ozcebe OI, Ozdemir O, Celik I, Dündar SV, Kirazli S. Impaired haemostatic kinetics and endothelial function in Behçet's disease. J Intern Med. 1996 Oct;240(4):181–187. [PubMed]
  • Joannides R, Haefeli WE, Linder L, Richard V, Bakkali EH, Thuillez C, Lüscher TF. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation. 1995 Mar 1;91(5):1314–1319. [PubMed]
  • Salvarani Carlo, Boiardi Luigi, Casali Bruno, Olivieri Ignazio, Ciancio Giovanni, Cantini Fabrizio, Salvi Fabrizio, Malatesta Renato, Govoni Marcello, Trotta Francesco, et al. Endothelial nitric oxide synthase gene polymorphisms in Behçet's disease. J Rheumatol. 2002 Mar;29(3):535–540. [PubMed]
  • Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA, Jr, Jansen-McWilliams L, D'Agostino RB, Kuller LH. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol. 1997 Mar 1;145(5):408–415. [PubMed]
  • Prior P, Symmons DP, Scott DL, Brown R, Hawkins CF. Cause of death in rheumatoid arthritis. Br J Rheumatol. 1984 May;23(2):92–99. [PubMed]
  • Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, du Berger R, Côte R, Grover SA, Fortin PR, Clarke AE, et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum. 2001 Oct;44(10):2331–2337. [PubMed]
  • Karrar A, Sequeira W, Block JA. Coronary artery disease in systemic lupus erythematosus: A review of the literature. Semin Arthritis Rheum. 2001 Jun;30(6):436–443. [PubMed]
  • Lima Domingos S N, Sato Emilia I, Lima Valter C, Miranda Fausto, Jr, Hatta Francisca H. Brachial endothelial function is impaired in patients with systemic lupus erythematosus. J Rheumatol. 2002 Feb;29(2):292–297. [PubMed]
  • Raza K, Thambyrajah J, Townend JN, Exley AR, Hortas C, Filer A, Carruthers DM, Bacon PA. Suppression of inflammation in primary systemic vasculitis restores vascular endothelial function: lessons for atherosclerotic disease? Circulation. 2000 Sep 26;102(13):1470–1472. [PubMed]
  • Dhillon R, Clarkson P, Donald AE, Powe AJ, Nash M, Novelli V, Dillon MJ, Deanfield JE. Endothelial dysfunction late after Kawasaki disease. Circulation. 1996 Nov 1;94(9):2103–2106. [PubMed]
  • Chang Hyun Kyu, Cheon Kyeong Soo. The clinical significance of a pathergy reaction in patients with Behcet's disease. J Korean Med Sci. 2002 Jun;17(3):371–374. [PMC free article] [PubMed]
  • Walsh PS, Metzger DA, Higuchi R. Chelex 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. Biotechniques. 1991 Apr;10(4):506–513. [PubMed]
  • Chang HK, Kim JU, Cheon KS, Chung HR, Lee KW, Lee IH. HLA-B51 and its allelic types in association with Behçet's disease and recurrent aphthous stomatitis in Korea. Clin Exp Rheumatol. 2001 Sep-Oct;19(5 Suppl 24):S31–S35. [PubMed]
  • Tesauro M, Thompson WC, Rogliani P, Qi L, Chaudhary PP, Moss J. Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2832–2835. [PMC free article] [PubMed]
  • Wang XL, Sim AS, Wang MX, Murrell GA, Trudinger B, Wang J. Genotype dependent and cigarette specific effects on endothelial nitric oxide synthase gene expression and enzyme activity. FEBS Lett. 2000 Apr 7;471(1):45–50. [PubMed]
  • Philip I, Plantefeve G, Vuillaumier-Barrot S, Vicaut E, LeMarie C, Henrion D, Poirier O, Levy BI, Desmonts JM, Durand G, et al. G894T polymorphism in the endothelial nitric oxide synthase gene is associated with an enhanced vascular responsiveness to phenylephrine. Circulation. 1999 Jun 22;99(24):3096–3098. [PubMed]
  • Wang XL, Mahaney MC, Sim AS, Wang J, Wang J, Blangero J, Almasy L, Badenhop RB, Wilcken DE. Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels. Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):3147–3153. [PubMed]
  • Tsukada T, Yokoyama K, Arai T, Takemoto F, Hara S, Yamada A, Kawaguchi Y, Hosoya T, Igari J. Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem Biophys Res Commun. 1998 Apr 7;245(1):190–193. [PubMed]
  • Oemar BS, Tschudi MR, Godoy N, Brovkovich V, Malinski T, Lüscher TF. Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis. Circulation. 1998 Jun 30;97(25):2494–2498. [PubMed]
  • Lakhanpal S, Tani K, Lie JT, Katoh K, Ishigatsubo Y, Ohokubo T. Pathologic features of Behçet's syndrome: a review of Japanese autopsy registry data. Hum Pathol. 1985 Aug;16(8):790–795. [PubMed]
  • Gül A. Behçet's disease: an update on the pathogenesis. Clin Exp Rheumatol. 2001 Sep-Oct;19(5 Suppl 24):S6–12. [PubMed]
  • Kiraz S, Ertenli I, Calgüneri M, Oztürk MA, Haznedaroglu IC, Altun B, Erman M, Celik I. Interactions of nitric oxide and superoxide dismutase in Behçet's disease. Clin Exp Rheumatol. 2001 Sep-Oct;19(5 Suppl 24):S25–S29. [PubMed]
  • Evereklioglu Cem, Turkoz Yusuf, Er Hamdi, Inaloz H Serhat, Ozbek Emin, Cekmen Mustafa. Increased nitric oxide production in patients with Behçet's disease: is it a new activity marker? J Am Acad Dermatol. 2002 Jan;46(1):50–54. [PubMed]
  • Er H, Evereklioglu C, Cumurcu T, Türköz Y, Ozerol E, Sahin K, Doganay S. Serum homocysteine level is increased and correlated with endothelin-1 and nitric oxide in Behçet's disease. Br J Ophthalmol. 2002 Jun;86(6):653–657. [PMC free article] [PubMed]
  • Orem A, Vanizor B, Cimşit G, Kiran E, Değer O, Malkoç M. Decreased nitric oxide production in patients with Behçet's disease. Dermatology. 1999;198(1):33–36. [PubMed]
  • Mirza GE, Karakük S, Er M, Güngörmü N, Karakük I, Saraymen R. Tear nitrite and nitrate levels as nitric oxide end products in patients with Behçet's disease and non-Behçet's uveitis. Ophthalmic Res. 2001 Jan-Feb;33(1):48–51. [PubMed]
  • Creager MA, Gallagher SJ, Girerd XJ, Coleman SM, Dzau VJ, Cooke JP. L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest. 1992 Oct;90(4):1248–1253. [PMC free article] [PubMed]

Figures and Tables

Figure 1
Analysis of the Glu298Asp polymorphism in exon 7 of the eNOS gene. Three kinds of restriction fragments are shown after digestion with Ban II: lane 1, size marker; lane 2, homozygote (Asp/Asp); lane 3, homozygote (Glu/Glu) lane 4, heterozygote (Glu/Asp). ...
Figure 2
Analysis of the VNTR polymorphism in intron 4 of the eNOS gene. The band of 420 bp indicates five repeats and the band of 393 bp indicates four repeats of the 27 bp: lane 1, size marker; lane 2, wild type (4b/b); lane 3, four and five repeats heterozygote ...

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Group

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...